OncoImmunity is Decision/Risk Analysis in Norway that focus on cell therapies business. Founded in 2014. They cover business area such as developer, bona fide immunogenic neoantigen, personalized cancer immunotherapy, optimal neoantigen target, truly personalize cancer vaccine, cell therapy, health institution, research organization, effective tool, optimum result, cancer immuno-therapy.
2014
( 10 years old in 2024 )
Cell Therapies
-
Oslo Cancer Cluster Innovation Park
Ullernchausséen 64
0379 Oslo
Norway
Private
developerbona fide immunogenic neoantigenpersonalized cancer immunotherapyoptimal neoantigen targettruly personalize cancer vaccinecell therapyhealth institutionresearch organizationeffective tooloptimum resultcancer immuno-therapy
* We use standard office opening hours in near OncoImmunity's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
OncoImmunity is Decision/Risk Analysis business from Norway that founded in 2014 (10 years old in 2024), OncoImmunity business is focusing on Cell Therapies.
OncoImmunity headquarter office and corporate office address is located in Oslo Cancer Cluster Innovation Park Ullernchausséen 64 0379 Oslo Norway.
OncoImmunity was founded in Norway.
In 2024, OncoImmunity is currently focus on cell therapies sector.
Above is snippet of Google Trends for "cell therapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with OncoImmunity, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
